US FDA Cuts Gender Language In Updated Clinical Trial Guidance

 
• By Manas Mishra
  
Gender-related language was removed in the reissued guidance. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Diversity & Inclusion

More from United States